We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Thin-Film, sEEG-Guided RF Ablation System Could Transform Neurosurgery Procedures

By HospiMedica International staff writers
Posted on 19 Dec 2023

A thin-film, sEEG-guided radiofrequency (RF) system capable of recording electrical activity as well as ablating nervous tissue with the added benefit of temperature control has the potential to transform neurosurgery procedures.

The OneRF Ablation System from NeuroOne Medical Technologies (Eden Prairie, MN, USA) is designed for creating RF lesions in nervous tissue for functional neurosurgical procedures. NeuroOne is known for developing and commercializing advanced thin-film electrodes that serve both diagnostic and therapeutic purposes, offering a more effective approach to treating various neurological conditions. The OneRF Ablation System is poised to revolutionize surgical practices, potentially allowing patients to undergo a single surgery for both diagnostic and therapeutic needs. This innovation could lead to reduced hospitalization duration, fewer surgeries, and fewer adverse events, all while providing substantial clinical advantages. The system's temperature control capability at the ablation point further enhances patient safety.


Image: The high-definition, minimally invasive thin film electrodes aids in diagnosis of neurological conditions (Photo courtesy of NeuroOne)
Image: The high-definition, minimally invasive thin film electrodes aids in diagnosis of neurological conditions (Photo courtesy of NeuroOne)

The system enables ablative therapy using depth electrodes that are already implanted for diagnosing the epileptic focus as part of stereoEEG. This development can lead to better patient outcomes, potentially requiring fewer medical interventions and offering an expanded therapeutic window. The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to NeuroOne's OneRF Ablation System, marking the company's first therapeutic device and third FDA-cleared product. The FDA approval empowers neurosurgeons with an important instrument in the surgical treatment of epilepsy. NeuroOne now offers a comprehensive range of electrode technology, catering to patients in need of diagnostic brain mapping procedures as well as RF ablation using the same sEEG electrode. Other FDA-cleared devices from NeuroOne include the Evo cortical and sEEG electrode product lines, primarily used for recording brain electrical activity for periods shorter than 30 days.

Related Links:
NeuroOne Medical Technologies


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscope
EB-500

Latest Surgical Techniques News

First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias

Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends

Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries